Dr. Ronak Delewi and Dr. C. Michael Gibson Discuss: Transcatheter Aortic Valve Implantation Without Routine Percutaneous Coronary Intervention: A Randomized Controlled Trial March 29, 2026 Disclosures: TBD
Dr. Wayne Batchelor and Dr. C. Michael Gibson Discuss: Automated Notifications to Improve Referral and Treatment of Severe Aortic Stenosis and Mitral Regurgitation: Outcomes From the Randomized Alert Trial March 29, 2026 Disclosures TBD
Dr. Hyo-Soo Kim and Dr. C. Michael Gibson Discuss: 10-year Follow-up of Clopidogrel Vs Aspirin Monotherapy in Stable Coronary Artery Disease After Percutaneous Coronary Intervention With Drug-eluting Stent March 29, 2026 Disclosures TBD
Dr. Michael Kleiner Shochat and Dr. C. Michael Gibson Discuss: Lung Impedance-Guided Therapy in Heart Failure With Preserved Ejection Fraction: Results of a Randomized Clinical Trial March 29, 2026 Disclosures TBD
Dr. Joost Daemen and Dr. C. Michael Gibson Discuss: Fractional Flow Reserve or 3d-quantitative Coronary Angiography-Based Vessel-Ffr Guided Revascularization – The Fast Iii Trial March 29, 2026 Disclosures TBD
Dr. William Fearon, Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: A Large-Scale, Global Randomized Trial of Coronary Physiology Derived From Conventional Angiography Compared With An Invasive Pressure Wire-Based Approach to Guide Percutaneous Coronary Intervention March 29, 2026 Disclosures TBD
Dr. Divaka Perera and Dr. C. Michael Gibson Discuss: Controlled Trial of High-Risk Coronary Intervention With Percutaneous Left Ventricular Unloading (CHIP-BCIS3) March 29, 2026 Disclosures TBD
Dr. Stephen Juraschek and Dr. C. Michael Gibson Discuss: DASH-Patterned Groceries to Reduce Blood Pressure Among Adults With Treated Hypertension: Results From the GoFreshRx Randomized Clinical Trial March 28, 2026 Disclosures TBD
Dr. Byeong-Keuk Kim and Dr. C. Michael Gibson Discuss: Intensive Low-Density Lipoprotein Cholesterol Targeting in Patients With Atherosclerotic Cardiovascular Disease March 28, 2026 Disclosures: TBD
Dr. Luke Laffin and Dr. C. Michael Gibson Discuss: Kardinal: A Phase 2 Study of Tonlamarsen For the Treatment of Uncontrolled Hypertension March 28, 2026 Disclosures: TBD
